Comparison of effectiveness of adjuvant imatinib therapy during 1 year versus 3 years and more in patients with high-risk resected Gastrointestinal stromal tumours
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
Most Recent Events
- 21 Jul 2016 New trial record